A skincare startup got bought for $190 million—then shut down. Here's what entrepreneurs can learn from the rise and fall of ...

SHOPPING: Give yourself the gift of improved sense of self with the once-a-day treatment that contains ingredients to support ...

Major cybersecurity breaches continue to plague the US healthcare industry, and on December 27, 2024, the U.S. Department of ...

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...

Before healthcare organizations implement artificial intelligence tools, they need foundational technology and policies in place and a culture ready to embrace innovation.

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Is the F.A.A. really ensuring safety by disqualifying pilots who receive a diagnosis or treatment? Troy Merritt, a pilot, ...

Discover how Duke University Health System is transforming healthcare with ambient AI technology, backed by evidence and solving pressing needs.

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.

For example, New Yorkers are two times more likely than New Orleanians to name willpower as a reason why they can't lose weight (39.5% vs. 19%) and nearly three times more likely than their neighbors ...

Walgreens was too big to fail entirely–but made too many mistakes and remained in too many dying segments. The Gimlet Eye credits Walgreens for making a good deal with private equity firm Sycamore ...